Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial (scientific article (publication date: 14 April 2004))

cites work (P2860)

Q84599965	Q84599965
Q95359087	Q95359087
Q37812132	'PROFOX'--the post HRT nightmare
Q37170186	17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women
Q39373446	17Beta-estradiol/levonorgestrel transdermal system for the management of the symptomatic menopausal woman
Q51740951	17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets.
Q45083258	17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy.
Q51789309	17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney.
Q45154796	17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats
Q37286111	17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice
Q33825736	17α-estradiol attenuates neuron loss in ovariectomized Dtg AβPP/PS1 mice.
Q89820452	17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
Q51119711	17β-Estradiol administration promotes delayed cutaneous wound healing in 40-week ovariectomised female mice.
Q34237961	17β-estradiol and inflammation: implications for ischemic stroke
Q35154584	2-methoxyestradiol induces vasodilation by stimulating NO release via PPARγ/PI3K/Akt pathway.
Q37385636	25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women
Q52341734	27-Hydroxycholesterol Is an Estrogen Receptor β-Selective Negative Allosteric Modifier of 17β-Estradiol Binding.
Q37236792	A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells
Q57157080	A Heartfelt Message, Estrogen Replacement Therapy: Use It or Lose It
Q47099534	A Prospective Investigation of Body Size, Body Fat Composition and Colorectal Cancer Risk in the UK Biobank
Q35035445	A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.
Q50047356	A Review of Phytoestrogens and Their Association With Pelvic Floor Conditions.
Q57055224	A Statistical Perspective on Prevention Trials: A View from the Women’s Health Initiative
Q57306192	A candidate gene approach to searching for low-penetrance breast and prostate cancer genes
Q45278471	A concise display of multiple end points for benefit-risk assessment
Q35121703	A critique of Women's Health Initiative Studies (2002-2006)
Q35068814	A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study
Q38023908	A decade post WHI, menopausal hormone therapy comes full circle--need for independent commission
Q38574181	A focus on the prognosis and management of ischemic heart disease in patients without evidence of obstructive coronary artery disease.
Q36683987	A guide to improving the care of patients with fragility fractures
Q37923980	A guide to the treatment of depression in women by estrogens
Q34753393	A higher burden of small low-density lipoprotein particles is associated with profound changes in the free androgen index in male adolescents.
Q35986045	A lack of ovarian function increases neuroinflammation in aged mice
Q34181031	A longitudinal study of the effect of genistein on bone in two different murine models of diminished estrogen-producing capacity
Q64935594	A new method to address unmeasured confounding of mortality in observational studies.
Q33633141	A new strategy for selective targeting of progesterone receptor with passive antagonists
Q37346584	A novel animal model to study hot flashes: no effect of gonadotropin-releasing hormone
Q45046562	A novel mechanism of non-feminizing estrogens in neuroprotection
Q37757013	A novel regimen of combination transdermal estrogen and intermittent vaginally administered progesterone for relief of menopausal symptoms
Q57225591	A population-based cohort study of HRT use and breast cancer in Korea
Q39364029	A practical guide to the management of menopausal symptoms in breast cancer patients
Q33820367	A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism
Q37127477	A regularized Hotelling's T(2) test for pathway analysis in proteomic studies
Q37638712	A review of the cardiovascular and breast actions of drospirenone in preclinical studies
Q26822460	A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events
Q36713568	A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.
Q34161156	A(nother) scientific strategy to prevent breast cancer in postmenopausal women by enhancing estrogen-induced apoptosis?
Q88614292	A-C Estrogens as Potent and Selective Estrogen Receptor-Beta Agonists (SERBAs) to Enhance Memory Consolidation under Low-Estrogen Conditions
Q46379180	Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate
Q37338824	Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen
Q35164579	Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing
Q37098920	Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE
Q29347039	Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Q88983080	Actividades preventivas en la mujer. Actualización PAPPS 2018
Q34213218	Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats
Q35870685	Acute pretreatment with estradiol protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia
Q33663800	Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts
Q36502941	Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy
Q37030687	Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen
Q38161857	Advances in menopausal therapy: the tissue-selective estrogen complex
Q30448720	Advances in the treatment of menopausal symptoms
Q91976352	Advantages of large medical record database for outcomes research: Insights into post-menopausal hormone therapy
Q35948653	Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence
Q40401497	After the Women's Health Initiative: decision making and trust of women taking hormone therapy
Q36380206	Age alters cerebrovascular inflammation and effects of estrogen
Q37273894	Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials
Q37193835	Age at natural menopause and risk of ischemic stroke: the Framingham heart study
Q36030921	Age-dependent reductions in mitochondrial respiration are exacerbated by calcium in the female rat heart
Q36164324	Aging and Loss of Circulating 17β-Estradiol Alters the Alternative Splicing of ERβ in the Female Rat Brain
Q28387247	Aging, estrogen loss and epoxyeicosatrienoic acids (EETs)
Q43873104	Alcohol consumption and body weight change in postmenopausal women: results from the Women's Health Initiative
Q37041238	Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study
Q46714065	Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial
Q51940084	Algorithm for prescription of HRT or ERT for postmenopausal women.
Q57074482	Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders
Q26865759	Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship
Q34158441	American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis
Q36959809	American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations
Q38628180	An Update on Hormone Therapy in Postmenopausal Women: Mini-Review for the Basic Scientist
Q33780223	An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals
Q51102543	An innovative program to provide adequate women's health education to residents with VA-based ambulatory care experiences.
Q27013070	An overview on the treatment of postmenopausal osteoporosis
Q35784054	An update on drugs for the treatment of menopausal symptoms
Q37059728	An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage
Q26771962	Androgen receptor (AR) in cardiovascular diseases
Q42008163	Androgens and the breast
Q48543740	Antidepressants from a public health perspective: re-examining effectiveness, suicide, and carcinogenicity.
Q42743106	Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase
Q37926914	Antiresorptive therapies for osteoporosis: a clinical overview
Q34810472	Application of machine learning methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes
Q37198459	Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
Q37398191	Aromatase excess in cancers of breast, endometrium and ovary
Q36946008	Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
Q36191587	Aromatase, breast cancer and obesity: a complex interaction
Q36407322	Arzoxifene: the development and clinical outcome of an ideal SERM.
Q35237981	Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol
Q43241333	Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens.
Q38459121	Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation
Q50782585	Association between alcohol intake and domain-specific cognitive function in older women.
Q36836702	Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis
Q37240444	Association of Age at Menopause With Incident Heart Failure: A Prospective Cohort Study and Meta-Analysis
Q37648677	Association of Female Reproductive Factors with Hypertension, Diabetes and LQTc in Chinese Women
Q36602044	Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis
Q45066154	Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma
Q37260827	Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women
Q37673461	Associations between Body Composition, Hormonal and Lifestyle Factors, Bone Turnover, and BMD.
Q37801387	Atherosclerosis and sex hormones: current concepts
Q39254200	Attitude of German gynecologists towards prescribing HRT before and after the WHI study
Q39233375	Attitude of German women towards hormone therapy: results of a lay survey
Q37388936	Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical
Q50986104	Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey.
Q36278168	Attitudes toward hormone replacement therapy in the new millennium: university physicians' and patients' perspectives
Q38039167	BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations
Q42172146	Barriers and motivations for women to participate in cardiovascular trials
Q37456060	Baseline serum estradiol and fracture reduction during treatment with hormone therapy: the Women's Health Initiative randomized trial
Q36964723	Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis
Q42284550	Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats
Q50783742	Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study.
Q34431707	Beneficial effects of hormone replacement therapy on periodontitis are vitamin D associated
Q35023437	Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older
Q40280431	Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity
Q38471535	Benefits and risks during HRT: main safety issue breast cancer
Q37321697	Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause
Q34666496	Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies
Q34828456	Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residents
Q33835661	Beyond frequency: who is most bothered by vasomotor symptoms?
Q40538058	Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
Q41549697	Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women
Q36533649	Biochemical markers surrogating on vascular effects of sex steroid hormones
Q37190890	Bioidentical hormone therapy: Nova Scotia pharmacists' knowledge and beliefs
Q24643351	Bioidentical hormones for menopausal hormone therapy: variation on a theme
Q34557379	Biological and chemical standardization of a hop (Humulus lupulus) botanical dietary supplement
Q37921312	Biomarkers for predicting postmenopausal coronary heart disease
Q59827301	Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative
Q37016594	Biostatistics primer: part I.
Q37091120	Black tea may be a prospective adjunct for calcium supplementation to prevent early menopausal bone loss in a rat model of osteoporosis
Q91984204	Blood pressure variability and brain morphology in elderly women without cardiovascular disease
Q38946960	Body Mass Index, Waist Circumference, and Mortality in a Large Multiethnic Postmenopausal Cohort-Results from the Women's Health Initiative
Q36597571	Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment
Q27012792	Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status
Q37672603	Bone physiology, disease and treatment: towards disease system analysis in osteoporosis
Q44242882	Bone, cartilage and hormone therapy: established concepts and future scenarios
Q36579224	Boosting for detection of gene-environment interactions
Q36491403	Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats
Q34708973	Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review
Q37413116	Brain volumes, cognitive impairment, and conjugated equine estrogens
Q30980873	Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
Q38627432	Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index
Q43267033	Breast cancer from oral and transdermal estradiol: a cohort study of Finnish women
Q37153908	Breast cancer in young women and its impact on reproductive function
Q33257142	Breast cancer risk associated with different HRT formulations: a register-based case-control study
Q35230186	Breast cancer risk factors in relation to breast density (United States).
Q34577224	Breast cancer risk in relation to the interval between menopause and starting hormone therapy
Q38620327	Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study
Q83801367	Breast cancer: Risk and mortality after oestrogen-alone therapy--is it safe?
Q36946802	Breast cancer: are estrogen metabolites carcinogenic?
Q36937185	Breast tenderness after initiation of conjugated equine estrogens and mammographic density change
Q36971892	Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials
Q30409045	Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
Q34704488	Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis
Q34723098	Brief report: attitudes toward hormone therapy after the Women's Health Initiative: a comparison of internists and gynecologists.
Q51154554	Burden of illness of hypertension among women using menopausal hormone therapy: a US perspective
Q36750746	CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
Q26784337	Calcium intake and bone mineral density: systematic review and meta-analysis
Q37441147	Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative
Q33939390	Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial
Q24653880	Calcium plus vitamin D supplementation and the risk of breast cancer
Q37053045	Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative
Q34016231	Calcium supplements and cardiovascular risk: 5 years on
Q28213284	Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials
Q38032972	Can breast cancer patients use soyafoods to help reduce risk of CHD?
Q35891395	Can hypnosis reduce hot flashes in breast cancer survivors? A literature review
Q36454421	Canadian Consensus Conference on osteoporosis, 2006 update.
Q95558181	Cancel the denosumab holiday
Q36841600	Cancer and cholesterol: understanding the V-shaped association in patients with diabetes
Q48629272	Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations
Q36410640	Cancer treatment-related bone loss: a review and synthesis of the literature
Q89993571	Cardiovascular Risk/Benefit Profile of MHT
Q49493589	Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study
Q54972686	Cardiovascular consequences of hormone therapy in postmenopausal women: Messages to clinicians.
Q37457697	Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study
Q35965092	Cardiovascular disease and primary ovarian insufficiency
Q37688153	Cardiovascular disease is preventable among women
Q33689317	Cardiovascular diseases in American women
Q37413163	Cardiovascular effects of noncardiovascular drugs
Q36561352	Cardiovascular health and the menopause: the gynecologist as the patients' interface
Q37994253	Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy
Q90236710	Cardiovascular implications of gender-affirming hormone treatment in the transgender population
Q36723824	Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches
Q45260501	Cardiovascular risks under hormone replacement therapy
Q41685808	Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials
Q36892860	Care of the menopausal patient: a nurse practitioner's view
Q50034085	Carrier-Free Microspheres of an Anti-Cancer Drug Synthesized via a Sodium Catalyst for Controlled-Release Drug Delivery.
Q26781860	Celebrating 75 years of oestradiol
Q36786766	Challenges to defining a role for progesterone in breast cancer
Q27026559	Challenging and complex decisions in the management of the BRCA mutation carrier
Q37567473	Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies
Q44074291	Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies
Q24814779	Changes in elderly women's health-related quality of life following discontinuation of hormone replacement therapy
Q81163509	Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy
Q51156233	Changes in hormone therapy prescriptions among middle-aged women in Taiwan: implications for health needs at menopause.
Q24658107	Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk
Q37237180	Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women
Q38313523	Changes of microRNA profile and microRNA-mRNA regulatory network in bones of ovariectomized mice.
Q35866374	Changing concepts: Menopausal hormone therapy and breast cancer
Q45062621	Changing the conversation about hormone therapy
Q59740118	Chapter 17 Stroke among women, ethnic groups, young adults, and children
Q87041760	Chapter 4.1: Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium
Q28196514	Chemoprevention in gastrointestinal cancers: current status
Q36306224	Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats
Q41826140	Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice
Q37104653	Chronic black tea extract consumption improves endothelial function in ovariectomized rats
Q48072972	Cimicifuga racemosa extract for relieving menopausal symptoms: a randomized controlled trial.
Q37638732	Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers
Q34559145	Circulating sex hormones and mammographic breast density among postmenopausal women
Q35659606	Circulating sex steroids and breast cancer risk in premenopausal women
Q57988316	Climacteric Commentaries
Q46877675	Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer
Q46728267	Clinical guide to the menopause and post-menopause
Q34568554	Clinical management of BRCA1 and BRCA2 mutation carriers
Q82241176	Clinical management of BRCA1 and BRCA2 mutation carriers
Q36169511	Clinical management of osteoporosis in women with a history of breast carcinoma
Q36754871	Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation
Q36568449	Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy
Q36568454	Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause.
Q35387233	Clinical research quo vadis? Trends in reporting of clinical trials and observational study designs over two decades
Q43053433	Clinical update on hormone replacement therapy
Q82306970	Clinical use of denosumab for the treatment for postmenopausal osteoporosis
Q34250632	Clinician's Guide to Prevention and Treatment of Osteoporosis
Q92242770	Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
Q52926373	Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.
Q89010134	Coagulation Factors in Ischemic Heart Disease: Answers From a Mendelian Randomization Study Inspire Further Questions
Q46153359	Cognitive Function and Changes in Cognitive Function as Predictors of Incident Cardiovascular Disease: The Women's Health Initiative Memory Study
Q40649220	Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis
Q45960420	Cognitive effects of short-term use of raloxifene: a randomized clinical trial.
Q92656269	Cognitive resilience among APOE ε4 carriers in the oldest old
Q47237452	Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people.
Q33284068	Colon cancer risk and different HRT formulations: a case-control study
Q37209821	Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study
Q37853558	Colorectal cancer screening and prevention in women
Q43267025	Combination of drospirenone and estradiol: a new hormone therapy in postmenopausal women
Q37728394	Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause
Q35557927	Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
Q36257886	Commentary: What's the deal with menopause management? Why the Women's Health Initiative raises more questions than it answers
Q36796694	Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate
Q37610396	Comparative effects of conventional vs. novel hormone replacement therapy on blood pressure in postmenopausal women
Q36974411	Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels
Q30655662	Comparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment
Q50715984	Comparison between phytoestrogens and estradiol in the prevention of atheroma in ovariectomized cholesterol-fed rabbits.
Q38684150	Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study
Q35975527	Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative
Q92056347	Comparison of the Efficacy of Tibolone and Transdermal Estrogen in Treating Menopausal Symptoms in Postmenopausal Women
Q56087724	Comparison of the effects of a new conjugated oral estrogen, estradiol-3β-glucoside, with oral micronized 17β-estradiol in postmenopausal women
Q37650744	Complexities of oestrogen in stroke
Q48166851	Comprehensive primary prevention of cardiovascular disease in women.
Q36135529	Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application
Q59433974	Confronting the challenges of the menopausal transition
Q55982498	Conjugated Equine Estrogen, Esterified Estrogen, Prothrombotic Variants, and the Risk of Venous Thrombosis in Postmenopausal Women
Q55379602	Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
Q37474363	Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial
Q37245244	Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study
Q34118386	Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial
Q36143058	Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
Q38193873	Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause
Q30659580	Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data
Q37016571	Considerations of study design
Q37138852	Contraceptive hormone use and cardiovascular disease
Q35591581	Coping with time scales in disease systems analysis: application to bone remodeling
Q46088939	Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial
Q28219423	Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment
Q44251617	Coronary heart disease and HRT in France: MISSION study prospective phase results
Q34788703	Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
Q33626048	Coronary heart disease in women: a challenge for the 21st century
Q36433568	Coronary heart disease in women: highlights of the past 2 years--stepping stones, milestones and obstructing boulders
Q40393652	Coronary heart disease in women: what do we know now?
Q28822502	Correlation of global risk assessment with cardiovascular complications in patients with diabetes mellitus living in Puerto Rico
Q37228878	Correspondence (letter to the editor): Causal Treatment for ADHD is Possible
Q37609391	Cost implications of new evidence on prevention of cardiovascular disease
Q36648725	Cost-effectiveness of the treatment and prevention of osteoporosis--a review of the literature and a reference model
Q34169103	Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians
Q30843682	Covariate measurement error correction methods in mediation analysis with failure time data.
Q34084652	CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Q40503693	Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women
Q59485356	Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons
Q33976634	Curcuma comosa improves learning and memory function on ovariectomized rats in a long-term Morris water maze test
Q36890431	Current and emerging therapies for the treatment of osteoporosis
Q36675379	Current breast cancer risks of hormone replacement therapy in postmenopausal women
Q36144183	Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women
Q46149673	Current patient perceptions on the menopause: a South African perspective
Q36669632	Current pharmacological options for the management of primary hyperparathyroidism
Q43267040	Current state of hormone replacement therapy: the case for using trimegestone
Q27302901	Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo
Q33371496	Data analysis methods and the reliability of analytic epidemiologic research
Q37600007	Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women.
Q37708128	Defining the conformation of the estrogen receptor complex that controls estrogen-induced apoptosis in breast cancer
Q50979514	Delay in post-ovariectomy estrogen replacement negates estrogen-induced augmentation of post-exercise muscle satellite cell proliferation.
Q60042090	Delayed wound healing in elderly people
Q33915401	Demographic and health factors associated with enrollment in posttrial studies: the Women's Health Initiative Hormone Therapy Trials
Q27009275	Denosumab for the treatment of osteoporosis
Q37679921	Denosumab--an emerging treatment for postmenopausal osteoporosis
Q38117062	Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management
Q48930833	Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study
Q33206783	Determinants of changes in bone mass and femoral neck structure, and physical performance after menopause: a 9-year follow-up of initially peri-menopausal women
Q46932963	Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors
Q37199923	Diagnosis and management of osteoporosis in the older senior
Q35050611	Dietary fiber and serum 16α-hydroxyestrone, an estrogen metabolite associated with lower systolic blood pressure
Q33333555	Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats
Q34192258	Dietary vitamin D and calcium intake and mammographic density in postmenopausal women
Q40025452	Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines
Q45841349	Differences Between Gynecologists and Primary Care Physicians in Hormone Therapy Prescribing: Why They Matter
Q33642558	Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination
Q45226665	Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets
Q36124064	Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause
Q33595324	Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice
Q37143947	Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys
Q33856406	Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer
Q46542073	Differential regulation of insulin resistance and hypertension by sex hormones in fructose-fed male rats
Q21284761	Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints
Q46686778	Discharge prescription for ischemic stroke patients
Q36088805	Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changes
Q35712301	Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met
Q35029513	Do aromatase inhibitors have adverse effects on cognitive function?
Q80306500	Does WHI tell us how to prevent diabetes?
Q40409927	Does hormone replacement therapy have a future?
Q47638270	Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective.
Q44689419	Does retention of the ovaries improve long-term survival after hysterectomy? Prophylactic oophorectomy
Q46157212	Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis?
Q45933090	Dose effects of oral estradiol on bone mineral density in Japanese women with osteoporosis.
Q36947507	Dose-dependent effects of a genistein-enriched diet in the heart of ovariectomized mice
Q37490810	Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis
Q80192444	Double jeopardy: hormone therapy on trial again
Q35827072	Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study
Q36826910	Driving with Mild Cognitive Impairment or Dementia: Cognitive Test Performance and Proxy Report of Daily Life Function in Older Women
Q36761429	Drospirenone and estradiol: a new option for the postmenopausal woman
Q28293272	Drospirenone and its antialdosterone properties
Q36850343	Drospirenone, a new progestogen, for postmenopausal women with hypertension
Q36672697	Drug insight: Existing and emerging therapies for osteoporosis
Q38612952	Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors
Q37079118	Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update
Q37735189	Drugs for the treatment of menopausal symptoms.
Q37582481	Dyslipidemia in women: etiology and management
Q64971370	ERβ agonist alters RNA splicing factor expression and has a longer window of antidepressant effectiveness than estradiol after long-term ovariectomy
Q33541294	EVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantage
Q33981652	Early menopausal hormone use influences brain regions used for visual working memory
Q36237441	Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis
Q46485057	Early postmenopausal bone loss and what to do about it.
Q36175903	Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature
Q38803432	Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis.
Q58781174	Effect of Aromatherapy on the Treatment of Psychological Symptoms in Postmenopausal and Elderly Women: A Systematic Review and Meta-analysis
Q37487595	Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial
Q46646681	Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women
Q52342343	Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.
Q90088619	Effect of alendronate or 8-prenylnaringenin applied as a single therapy or in combination with vibration on muscle structure and bone healing in ovariectomized rats
Q42801121	Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Q36183109	Effect of combined sex hormone replacement on bone/cartilage turnover in a murine model of osteoarthritis
Q35894901	Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age
Q51334209	Effect of estradiol on the expression of renal sodium transporters in rats.
Q36516411	Effect of hormone replacement therapy (HRT) on periodontal status of postmenopausal women
Q34717132	Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials
Q34163992	Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status
Q35243693	Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.
Q34348683	Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials
Q43646550	Effect of long-term, high-dose estrogen treatment on prolactin levels: a retrospective analysis.
Q40496635	Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.
Q46912019	Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression
Q47351023	Effect of porcine placental extract on the mild menopausal symptoms of climacteric women.
Q28274641	Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women
Q51163066	Effect of the ethanol extract of Pleurotus eryngii on bone metabolism in ovariectomized rats.
Q51889692	Effect of the women's health initiative on prescription anti-osteoporosis medication utilization.
Q34863717	Effect of transdermal estrogen therapy on bone mineral density in postmenopausal korean women
Q37788769	Effectiveness of phytoestrogens in climacteric medicine
Q40437487	Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial
Q33661422	Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial.
Q93049281	Effects of Estrogens on Platelets and Megakaryocytes
Q36909383	Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study
Q38499906	Effects of Oestrogen Treatment on Skeletal Response to Exercise in the Hips and Spine in Postmenopausal Women: A Meta-Analysis
Q64083242	Effects of Rhizoma Drynariae Cataplasm on Fracture Healing in a Rat Model of Osteoporosis
Q44302169	Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women
Q36626118	Effects of bazedoxifene alone and with conjugated equine estrogens on coronary and peripheral artery atherosclerosis in postmenopausal monkeys
Q36761442	Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women
Q45250159	Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat.
Q37417437	Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy
Q64905896	Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice.
Q39581323	Effects of different progestogens on human breast tumor cell growth
Q46268406	Effects of drospirenone on cardiovascular markers in human aortic endothelial cells
Q36974408	Effects of dydrogesterone on the vascular system
Q46448333	Effects of electro-acupuncture on oestrogen levels, body weight, articular cartilage histology and MMP-13 expression in ovariectomised rabbits
Q51401165	Effects of estradiol-drospirenone hormone treatment on carotid artery intima-media thickness and vertigo/dizziness in postmenopausal women.
Q37183332	Effects of estrogen on platelet reactivity after transient forebrain ischemia in rats
Q37301811	Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux
Q37268102	Effects of gender and sex steroids on ischemic injury
Q84098205	Effects of long-term hormone replacement therapy: results from a cohort study
Q36066982	Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats
Q43836825	Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast
Q49578334	Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials
Q37140905	Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials
Q43120315	Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis
Q46560125	Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women
Q39536034	Effects of red clover extracts on breast cancer cell migration and invasion
Q37370988	Effects of short-term administration of estradiol on reperfusion arrhythmias in rats of different ages
Q33522520	Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial
Q47290429	Effects of the Kampo medication keishibukuryogan on blood pressure in perimenopausal and postmenopausal women
Q30353161	Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice
Q36905110	Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors
Q47339499	Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances.
Q46905068	Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause
Q37439245	Effects of two years of conjugated equine estrogens on cholinergic neurons in young and middle-aged ovariectomized monkeys
Q36550935	Efficacy and side effects of chinese herbal medicine for menopausal symptoms: a critical review
Q36648982	Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: a multicenter, randomized, double-blind, placebo-controlled trial.
Q48226514	Efficacy of porcine placental extract on climacteric symptoms in peri- and postmenopausal women
Q34658162	Efficacy of porcine placental extract on wrinkle widths below the eye in climacteric women
Q30560613	Efficacy of yoga for vasomotor symptoms: a randomized controlled trial
Q36606365	Egg harvesting for stem cell research: medical risks and ethical problems
Q41996527	Elevated ischemic stroke risk among women living with HIV infection
Q34700462	Elevated t/e2 ratio is associated with an increased risk of cerebrovascular disease in elderly men
Q48012226	Emerging anabolic agents in the treatment of osteoporosis
Q36099415	Emerging and potential therapies for osteoporosis
Q38307019	Emerging hormonal treatments for menopausal symptoms
Q36944034	Emerging pharmacologic therapies for osteoporosis
Q36383775	Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women
Q36800936	Endogenous estrogen attenuates hypoxia-induced pulmonary hypertension by inhibiting pulmonary arterial vasoconstriction and pulmonary arterial smooth muscle cells proliferation
Q47699095	Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).
Q46862560	Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women
Q35198259	Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient
Q37855938	Endometrial cancer, types, prognosis, female hormones and antihormones
Q37483322	Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model
Q36753822	Endothelial Estrogen Receptor-α Does Not Protect Against Vascular Stiffness Induced by Western Diet in Female Mice.
Q33693303	Endothelial estrogen receptor isoforms and cardiovascular disease
Q83194245	Endothelial function and cerebrovascular disease: implications for diagnosis and treatment
Q36442450	Endothelial function is impaired across the stages of the menopause transition in healthy women
Q35915312	Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI).
Q38319580	Environmental (nongenetic) factors in gynecological cancers: update and future perspectives
Q38986410	Environmental and Genetic Risk Factors Associated with Venous Thromboembolism
Q42833070	Epidemiology of coronary heart disease in women
Q37306273	Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study
Q56779064	Epidemiology, Lifestyle, and Environmental Factors
Q61806412	Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling
Q38708380	Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
Q34281991	Erythroid promoter confines FGF2 expression to the marrow after hematopoietic stem cell gene therapy and leads to enhanced endosteal bone formation
Q37275947	Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women
Q35741878	Established risk factors account for most of the racial differences in cardiovascular disease mortality
Q36954077	Estradiol attenuates neuroprotective benefits of isoflurane preconditioning in ischemic mouse brain
Q51782145	Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.
Q33756940	Estradiol is a potent protective, restorative, and trophic factor after brain injury.
Q43267074	Estradiol topical emulsion for the treatment of moderate-to-severe vasomotor symptoms associated with menopause
Q34627684	Estrogen Enhances Neurogenesis and Behavioral Recovery after Stroke
Q64081852	Estrogen Modulates Cartilage and Subchondral Bone Remodeling in an Ovariectomized Rat Model of Postmenopausal Osteoarthritis
Q41118138	Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.
Q53184778	Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.
Q33558982	Estrogen Secreted by Mesenchymal Stem Cells Necessarily Determines Their Feasibility of Therapeutical Application.
Q34481021	Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics
Q37610373	Estrogen actions in the cardiovascular system
Q30447470	Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms
Q38982905	Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial
Q37373590	Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial
Q33898159	Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy
Q42491540	Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys.
Q35812293	Estrogen and Cardiovascular Disease: Is Timing Everything?
Q42329959	Estrogen and breast cancer: can less mean more?
Q41699978	Estrogen and colorectal cancer incidence and mortality
Q36590813	Estrogen and hypertension
Q37238436	Estrogen and mechanisms of vascular protection
Q36380215	Estrogen and progestagens differentially modulate vascular proinflammatory factors
Q33917508	Estrogen and progesterone-related gene variants and colorectal cancer risk in women
Q38011781	Estrogen and progestogen effect on venous thromboembolism in menopausal women
Q24658109	Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society
Q37895671	Estrogen and skin: therapeutic options
Q33595388	Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation
Q37390344	Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys
Q28573241	Estrogen deficiency decreases ischemic tolerance in the aged rat heart: Roles of PKCdelta, PKCepsilon, Akt, and GSK3beta
Q45265162	Estrogen depletion differentially affects blood pressure depending on age in Long-Evans rats
Q34487849	Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors.
Q43053682	Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females
Q35162962	Estrogen in cardiovascular disease during systemic lupus erythematosus
Q47097266	Estrogen modulates vascular smooth muscle cell function through downregulation of SIRT1.
Q36976159	Estrogen plus progestin and risk of benign proliferative breast disease
Q37163009	Estrogen plus progestin therapy and breast cancer in recently postmenopausal women
Q34096513	Estrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities
Q37610371	Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology
Q34447516	Estrogen receptor activation and cardioprotection in ischemia reperfusion injury
Q35605843	Estrogen receptor beta does not influence ischemic tolerance in the aged female rat heart
Q37435948	Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen
Q36861119	Estrogen receptor is activated by korean red ginseng in vitro but not in vivo
Q34782068	Estrogen receptor polymorphisms and the vascular effects of hormone therapy
Q64355675	Estrogen receptor subcellular localization and cardiometabolism
Q90378154	Estrogen receptor-α in female skeletal muscle is not required for regulation of muscle insulin sensitivity and mitochondrial regulation
Q37814931	Estrogen receptors: therapies targeted to receptor subtypes
Q33891395	Estrogen replacement and skeletal muscle: mechanisms and population health
Q36854654	Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS.
Q43191183	Estrogen replacement therapy after endometrial cancer: a survey of physicians' prescribing practice
Q34481216	Estrogen signaling in metabolic inflammation
Q52665446	Estrogen therapy for osteoporosis in the modern era.
Q36658946	Estrogen therapy for postmenopausal osteoporosis
Q36187913	Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.
Q28383144	Estrogen, aging and the cardiovascular system
Q35070227	Estrogen, hormonal replacement therapy and cardiovascular disease
Q36621171	Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.
Q88604005	Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study
Q33583043	Estrogen-mimicking isoflavone genistein prevents bone loss in a rat model of obstructive sleep apnea-hypopnea syndrome
Q38599114	Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization
Q80815527	Estrogens and Stroke: Use of Oral Contraceptives and Postmenopausal Use of Estrogen: Current Recommendations
Q34449454	Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative
Q43558031	Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.
Q38739583	Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury
Q46946609	Ethnic differences in femur geometry in the women's health initiative observational study
Q24612411	European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Q37037296	European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Q57465255	European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Q41967638	Evidence for the treatment of osteoporosis with vitamin D in residential care and in the community dwelling elderly
Q34239340	Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen
Q24288834	Evidence-Based Medicine as a Tool for Undergraduate Probability and Statistics Education
Q38011787	Evidence-based assessment of the impact of the WHI on women's health.
Q57594175	Exercise in Menopausal Women
Q34827484	Exogenous Estrogen Does Not Attenuate the Association Between Rofecoxib and Myocardial Infarction in Perimenopausal Women
Q52985664	Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study.
Q37008462	Exogenous and endogenous hormones and breast cancer
Q39294765	Experience of hormone replacement therapy among women of Sarawak, Malaysia
Q33357034	Experiences of a long-term randomized controlled prevention trial in a maiden environment: Estonian Postmenopausal Hormone Therapy trial
Q36648823	Exploring the contribution of estrogen to amyloid-Beta regulation: a novel multifactorial computational modeling approach
Q36632865	Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk
Q36792134	Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk
Q92840732	Expression of PGRMC1 in paraffin-embedded tissues of breast cancer
Q46933035	Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal women.
Q33355956	Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton
Q37803403	Factors associated with non-compliance with hormone therapy cessation before screening mammography
Q57461351	Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults
Q36901959	Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model
Q35838049	Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?
Q38332049	Female-specific factors for IHD: across the reproductive lifespan
Q56673117	Five Decades of Hormone Therapy Research: The Long, the Short, and the Inconclusive
Q33524436	Flaxseed does not antagonize the effect of ultra-low-dose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats
Q83188238	Folate supplementation and cardiovascular disease
Q35034379	Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study.
Q90650484	Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women
Q84035888	Fracture prevention in postmenopausal women
Q93501199	Fracture prevention in postmenopausal women
Q35657905	From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.
Q35119666	Functional maintenance of differentiated embryoid bodies in microfluidic systems: a platform for personalized medicine
Q38025048	Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling.
Q37038222	Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms
Q31085620	Futility approaches to interim monitoring by data monitoring committees
Q33980902	Future antidepressants: what is in the pipeline and what is missing?
Q39615279	Future long-term trials of postmenopausal hormone replacement therapy - what is possible and what is the optimal protocol and regimen?
Q38662523	Future of the transdermal drug delivery market--have we barely touched the surface?
Q37444596	GPER-novel membrane oestrogen receptor
Q36654917	GPER1/GPR30 activation improves neuronal survival following global cerebral ischemia induced by cardiac arrest in mice
Q35023822	Gender differences in cardiovascular disease: hormonal and biochemical influences.
Q37427243	Gender differences in coronary artery disease: review of diagnostic challenges and current treatment
Q39094428	Gender differences in neurologic emergencies part I: a consensus summary and research agenda on cerebrovascular disease
Q43672165	Gender differences in the cardiovascular effect of sex hormones
Q33771819	Gender dimorphisms in progenitor and stem cell function in cardiovascular disease
Q35095785	Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges
Q36418348	Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study
Q43267036	Gender-specific care of diabetes
Q37169720	Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women
Q51664849	Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer.
Q40282547	Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women
Q42375844	Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
Q35557640	Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
Q33862850	Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women
Q30491822	Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk
Q88790402	Genome-based biomarkers for adverse drug effects, patient enrichment and prediction of drug response, and their incorporation into clinical trial design
Q35021642	Genome-wide association study of breast cancer in the Japanese population
Q34137268	Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells
Q37028001	Global cognitive function before, surrounding, and after ischemic stroke: the role of risk and protective factors varies with time among ischemic stroke survivors
Q35601856	Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment
Q50732504	Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies.
Q37396676	Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone
Q53597256	Guidelines for hormone replacement therapy of Asian women during the menopausal transition and thereafter.
Q35903489	Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013.
Q22306361	Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Q34126089	Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy
Q34132096	Gynaecological aspects of the treatment and follow-up of transsexual men and women
Q37192947	Gynecologic cancers associated with Lynch syndrome/HNPCC.
Q46124392	HRT does not prevent chronic disease after menopause
Q37847568	HRT in difficult circumstances: are there any absolute contraindications?
Q47158979	Habitual aerobic exercise does not protect against micro- or macrovascular endothelial dysfunction in healthy estrogen-deficient postmenopausal women
Q38011779	Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.
Q90087822	Health considerations for transgender women and remaining unknowns: a narrative review
Q36851595	Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial
Q34736663	Heart disease and hormones
Q37585303	Heart failure in women: epidemiology, biology and treatment
Q47823963	Heartwood extract from Dalbergia sissoo promotes fracture healing and its application in ovariectomy-induced osteoporotic rats.
Q46976029	Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheep
Q22305468	High Prevalence of Vitamin D Inadequacy and Implications for Health
Q36366159	High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study.
Q46547398	High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats
Q36436644	Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization
Q30370870	Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices
Q60537409	Hormesis and Female Sex Hormones
Q35536136	Hormonal and nutritional effects on cardiovascular risk markers in young women
Q33246038	Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study
Q39353579	Hormonal therapy of menopause: 2004 position of the Department of Female Endocrinology and Andrology of the Brazilian Society of Endocrinology and Metabolism
Q37029421	Hormonal treatment, mild cognitive impairment and Alzheimer's disease
Q88516911	Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
Q93492613	Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)
Q49919950	Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative
Q35815464	Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients
Q82194744	Hormone in the hot seat
Q33721579	Hormone replacement therapy after prophylactic adnexectomy
Q91129420	Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits
Q42532733	Hormone replacement therapy after the menopause--where are we now?
Q46034947	Hormone replacement therapy and breast cancer risk in California.
Q33912797	Hormone replacement therapy and breast cancer: estimate of risk
Q37180364	Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density
Q34480637	Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect
Q80552811	Hormone replacement therapy and ovarian cancer risk: a meta-analysis
Q35981132	Hormone replacement therapy and peripheral vascular disease in women
Q36144161	Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
Q24647720	Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
Q22252375	Hormone replacement therapy and the association with coronary heart disease and overall mortality: Clinical application of the timing hypothesis
Q37909897	Hormone replacement therapy and the risk of breast cancer
Q55039004	Hormone replacement therapy decreases the risk of tinnitus in menopausal women: a nationwide study.
Q39702876	Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women
Q33554786	Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care
Q37153431	Hormone replacement therapy has no routine role in the management of postmenopausal voiding dysfunction
Q36739263	Hormone replacement therapy in breast cancer survivors
Q37862831	Hormone replacement therapy in gynecologic cancer survivors: why not?
Q36668526	Hormone replacement therapy in menopausal women: Past problems and future possibilities
Q39207067	Hormone replacement therapy in menopause
Q34315109	Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting
Q36610725	Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany
Q36240364	Hormone replacement therapy: an update
Q89752163	Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North America
Q37879678	Hormone therapy administration in postmenopausal women and risk of stroke
Q33261267	Hormone therapy after the Women's Health Initiative: a qualitative study
Q36946798	Hormone therapy and breast cancer risk
Q36686804	Hormone therapy and cardiovascular disease
Q31111946	Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited
Q37608577	Hormone therapy and cardiovascular risk markers and disease: focus on progestagens
Q43740719	Hormone therapy and colorectal cancer
Q38791860	Hormone therapy and large bowel cancer revisited
Q37610399	Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Q36916140	Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
Q36909204	Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials
Q37713006	Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity
Q37412972	Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study
Q92393629	Hormone therapy for first-line management of menopausal symptoms: Practical recommendations
Q24197712	Hormone therapy for preventing cardiovascular disease in post-menopausal women
Q24187326	Hormone therapy for preventing cardiovascular disease in post-menopausal women
Q37867308	Hormone therapy for the management of menopausal symptoms: pharmacotherapy update
Q36993374	Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?
Q46877668	Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Q37203453	Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials
Q46834697	Hormone therapy in menopause: when not to use
Q37309805	Hormone therapy in relation to survival from large bowel cancer.
Q36459544	Hormone therapy in the WHI era.
Q46060638	Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits
Q35040292	Hormone therapy use in women veterans accessing veterans health administration care: a national cross-sectional study.
Q33884570	Hormone therapy, DNA methylation and colon cancer
Q36887336	Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Q36385015	Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial
Q36533644	Hormone therapy: maximizing the benefits
Q28730966	Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study
Q36616567	Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study
Q34593579	Hormone-dependent aging problems in women
Q36396400	Hormone-related headache: pathophysiology and treatment
Q57961654	Hormone-replacement therapy and lobular cancers: new deals and old myths
Q33248484	Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study
Q38975101	Hormone-replacement therapy: current thinking
Q35948667	Hormones and bone health in postmenopausal women
Q46287307	Hormones and cardiovascular disease
Q36084247	Hormones and depression in women
Q30988720	Hormones and endometrial cancer--new data from the Million Women Study
Q35852845	Hormones and pregnancy: thromboembolic risks for women
Q35979363	Hormones, menopause, and heart disease: making sense of the Women's Health Initiative
Q41414568	How can information on the risk of breast cancer and hormone therapy be better understood?
Q36492900	How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy
Q61881610	How much can current interventions reduce colorectal cancer mortality in the U.S.?
Q37824642	How to judge the association of postmenopausal hormone therapy and the risk of breast cancer
Q46755958	How to stay heart healthy in 2011: considerations for the primary prevention of cardiovascular disease in women
Q37742631	Hypertension in women: the role of progesterone and aldosterone
Q36492399	Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study
Q28194282	IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy
Q44134557	IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
Q35233878	Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation
Q35774584	Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging
Q28200604	Impact of cyclooxygenase inhibitors in the Women's Health Initiative hormone trials: secondary analysis of a randomized trial
Q37046031	Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial
Q35183041	Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts.
Q52589476	Impact of hormone therapy on Medicare spending in the Women's Health Initiative randomized clinical trials.
Q37538095	Impact of ovarian function on cardiovascular health in women: focus on hypertension
Q64063642	Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions
Q42646024	Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.
Q36031290	Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study
Q34116953	Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells
Q33862138	In Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal Women
Q47163970	In vivo transplantation of 3D encapsulated ovarian constructs in rats corrects abnormalities of ovarian failure
Q35092609	Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan
Q35316886	Increased estrogen receptor β in adipose tissue is associated with increased intracellular and reduced circulating adiponectin protein levels in aged female rats
Q36027022	Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study
Q57788471	Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study
Q43775712	Increased risk of recurrence after hormone replacement therapy in breast cancer survivors
Q37905818	Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits
Q36835343	Inducible nitric oxide synthase and estradiol exhibit complementary neuroprotective roles after ischemic brain injury
Q37304927	Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy
Q35050971	Influence of lifestyle factors on breast cancer risk
Q37581402	Influence of menopause on diabetes and diabetes risk
Q46922683	Influence of oestrogenic compounds on monoamine transporters in rat striatum
Q33721061	Influence of sex hormones and phytoestrogens on heart disease in men and women
Q57664322	Influências da reposição de estrógenos e progestágenos na ação do hormônio de crescimento em mulheres com hipopituitarismo
Q88707623	Injection of synthetic mesenchymal stem cell mitigates osteoporosis in rats after ovariectomy
Q36690975	Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.
Q37997180	Insulin resistance: a significant risk factor of endometrial cancer
Q60042089	Insulin-Like Growth Factor-1 Promotes Wound Healing in Estrogen-Deprived Mice: New Insights into Cutaneous IGF-1R/ERα Cross Talk
Q104073603	Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer
Q38800155	Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk
Q40071035	Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium
Q38697912	Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
Q37943751	Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis
Q30245459	Interpretation of the evidence for the efficacy and safety of statin therapy
Q35958716	Interviews With Two Women's Health Experts On the Use of Estrogen Therapies.
Q28742085	Intestinal tumorigenesis is not affected by progesterone signaling in rodent models
Q91166020	Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors
Q37436161	Intraindividual variability in domain-specific cognition and risk of mild cognitive impairment and dementia
Q37727436	Involvement of estrogen receptor-β in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation
Q36645276	Is HRT justified for symptom management in women at higher risk of developing breast cancer?
Q44592446	Is There a Role for Menopausal Hormone Therapy (MHT) for Cardiovascular Disease Prevention in Select Postmenopausal Women?
Q36189328	Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Q43891179	Is postmenopausal hormone replacement therapy suitable after a cardio- or cerebrovascular event?
Q34288033	Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study
Q37174865	Is research on hormones and aging finished? No! Just started!
Q81002469	Is the WHI relevant to HRT started in the perimenopause?
Q36349751	Is there a link between oestrogen therapy and gallbladder disease?
Q90728387	Is there a role for reproductive steroids in the etiology and treatment of affective disorders?
Q37504631	Is there any relationship between different phenotypes of metabolic syndrome and cardiovascular mortality rate?
Q37018510	Is timing everything? New insights into why the effect of estrogen therapy on memory might be age dependent
Q46930374	Isoflavone supplementation influenced levels of triglyceride and luteunizing hormone in Korean postmenopausal women
Q36535984	Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.
Q37135281	Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.
Q36970351	Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.
Q37196548	Joint position statement of the Polish Cardiologic Society, the Polish Gynaecological Society and the Polish Menopause and Andropause Society on the effect of postmenopausal hormone replacement therapy on the cardiovascular system.
Q38853529	Knowledge and attitudes of health professionals regarding menopausal hormone therapies
Q55365443	Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance.
Q24812555	Large mobile thrombus in non-atherosclerotic thoracic aorta as the source of peripheral arterial embolism
Q37412956	Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Q43599484	Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy
Q34319242	Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Q37032563	Lifetime hormonal factors may predict late-life depression in women.
Q35062217	Liganded and unliganded activation of estrogen receptor and hormone replacement therapies
Q34736075	Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy
Q46802785	Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
Q37240036	Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials
Q24647962	Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist
Q84378916	Listening to the sound of silence between men and women
Q35543364	Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart
Q24201974	Long term hormone therapy for perimenopausal and postmenopausal women
Q24241279	Long term hormone therapy for perimenopausal and postmenopausal women
Q24246577	Long term hormone therapy for perimenopausal and postmenopausal women
Q39175806	Long-Term Hormone Replacement Therapy Is Associated with Low Coronary Artery Calcium Levels in a Cohort of Older Women: The Age, Gene/Environment Susceptibility-Reykjavik Study
Q35917069	Long-cycle treatment with oral contraceptives
Q30368543	Long-term drug prevention trials.
Q34048789	Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension
Q37352051	Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years
Q30238978	Long-term hormone therapy for perimenopausal and postmenopausal women
Q39934818	Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
Q34272056	Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
Q44294782	Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial
Q33685435	Long-term supplementation with young coconut juice does not prevent bone loss but rather alleviates body weight gain in ovariectomized rats
Q36974425	Long-term use of progestogens: colon adenoma and colon carcinoma
Q37128622	Longitudinal assessment of the effects of oestrogen on blood pressure and cardiovascular autonomic activity in female rats
Q36731679	Loss-of-function deletion of the steroid receptor coactivator-1 gene in mice reduces estrogen effect on the vascular injury response
Q37433589	Low-fat diet and skin cancer risk: the women's health initiative randomized controlled dietary modification trial
Q37194468	Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial
Q28607716	Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens
Q36285977	Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study
Q34145853	Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial
Q38012208	MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms
Q34649417	Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women
Q33566626	Mammographic screening and risk factors for breast cancer
Q35919125	Management of age-related osteoporosis and prevention of associated fractures
Q37020195	Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists
Q34722828	Management of dyslipidemia in women in the post-hormone therapy era.
Q37967044	Management of hypertension in women
Q36243750	Management of menopausal symptoms in patients with breast cancer: an evidence-based approach
Q38720569	Management of menopausal symptoms in women with gynecologic cancers
Q38156702	Management of microvascular angina pectoris
Q24795473	Management of osteoporosis
Q84757653	Management of urinary incontinence
Q35742248	Managing the menopause.
Q36508076	Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.
Q38086244	Matters of the heart: cardiovascular disease in U.S. women.
Q36511916	Mechanisms of neuroprotection by estrogen
Q34086924	Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells
Q39865023	Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Q46602710	Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells
Q56089167	Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer
Q40045531	Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials
Q37349131	Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends
Q47617240	Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation
Q36152764	Menopausal hormone therapy
Q38006917	Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
Q27022201	Menopausal hormone therapy and breast cancer mortality: clinical implications
Q37370478	Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort
Q34315478	Menopausal hormone therapy and cancer: changing clinical observations of target site specificity
Q37658616	Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials
Q34480625	Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study
Q48053728	Menopausal hormone therapy and quality of life: too many pyjamas
Q37102553	Menopausal hormone therapy and risk of colorectal cancer
Q28392391	Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials
Q60047406	Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: Findings from the Women's Health Initiative
Q35903637	Menopausal hormone therapy and venous thromboembolism
Q44200265	Menopausal hormone therapy for cardiovascular protection--unfulfilled expectations
Q38626233	Menopausal hormone therapy for primary prevention: why the USPSTF is wrong
Q37016116	Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen
Q34341907	Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort study
Q33741434	Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study
Q38106504	Menopausal hormone therapy: examining cardiovascular and clinical impacts of treatment.
Q93043418	Menopausal hormones: definitive evidence for breast cancer
Q37919098	Menopausal hot flushes and night sweats: where are we now?
Q37831337	Menopausal hot flushes and vascular health.
Q37685675	Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements
Q37163204	Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial
Q46457844	Menopausal women's perceived causes of hot flash
Q56453537	Menopause
Q43028519	Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy
Q83226488	Menopause and osteoporosis
Q82562281	Menopause hormonal therapy from the urologist's perspective
Q36645280	Menopause in Egypt: past and present perspectives
Q37650406	Menopause management: a cardiovascular risk-based approach
Q37314283	Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60-64 Years: A British Birth Cohort
Q40540489	Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4).
Q30431992	Menstrual cycle-related exacerbation of disease
Q40238961	Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women.
Q36570589	Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women
Q37077751	Metabolic and clinical consequences of hyperthyroidism on bone density
Q92379035	Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
Q43607131	Metformin and the risk of endometrial cancer: a population-based cohort study
Q46790716	Methodology of the inquiry MISSION (menopause, breast cancer risk, morbidity and prevalence)
Q37995322	Micronized progesterone and its impact on the endometrium and breast vs. progestogens
Q35058603	Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease
Q37608416	Migraine and cardiocerebrovascular risk in women.
Q27005632	Mitochondria as a therapeutic target in heart failure
Q55177681	Mitochondria, Estrogen and Female Brain Aging.
Q36517144	Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations
Q34062334	Modification of blood pressure in postmenopausal women: role of hormone replacement therapy
Q38097311	Modulating T regulatory cells in cancer: how close are we?
Q37255036	Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling
Q26797207	Molecular cancer prevention: Current status and future directions
Q27648855	Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of Premarin
Q37166756	Molecular mechanisms underlying progesterone-enhanced breast cancer cell migration
Q28249558	Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study
Q37689559	Monitoring pharmacological therapy for osteoporosis
Q31122463	Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board
Q38068600	Monoclonal antibodies for the treatment of osteoporosis
Q33244231	More data on hormone therapy and coronary artery disease: comments on recent publications from the WHI and Nurses' Study
Q46010647	Mortality Associated with Hormone Replacement Therapy in Younger and Older Women.
Q38042004	Mortality and morbidity in adult craniopharyngioma
Q42390529	Mortality associated with hormone replacement therapy in younger and older women
Q36611546	Mortality in women given diethylstilbestrol during pregnancy.
Q92853434	Multiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders
Q36511912	Multiple pathways transmit neuroprotective effects of gonadal steroids
Q46581013	Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women
Q55091399	Nanomedicine applications in women's health: state of the art.
Q37349494	Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice.
Q36237862	Neuroendocrinology of female aging
Q64460778	Neuroimmunology of the female brain across the lifespan: Plasticity to psychopathology
Q38005895	Neuroprotection and estrogen receptors
Q36102771	Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications
Q82331363	New Approaches to the Treatment of Osteoporosis
Q38014515	New developments in the treatment of osteoporosis
Q37056135	New evidence rekindles the hormone therapy debate
Q36939490	New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation
Q40953525	New insight on a possible mechanism of progestogens in terms of breast cancer risk.
Q46407690	New thoughts about estrogen therapy from the Women's Health Initiative
Q46446903	New treatments in osteoporosis
Q31070019	No Association between Dietary Patterns and Risk for Cognitive Decline in Older Women with 9-Year Follow-Up: Data from the Women's Health Initiative Memory Study
Q40486375	No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative
Q45928208	No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
Q35066087	Non-conventional hormone therapy - Tissue-specific Tibolone-Caution
Q36864701	Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways
Q47987919	Non-health Care Facility Medication Errors Associated with Hormones and Hormone Antagonists in the United States
Q24235391	Non-hormonal interventions for hot flushes in women with a history of breast cancer
Q34117657	Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative
Q97419539	Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells
Q34073510	Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling
Q49168066	Number of women needed in a prospective trial to prove potential cardiovascular benefit of hormone replacement therapy
Q47774103	O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer
Q89748011	Obesity and cardiovascular disease in women
Q34238727	Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease
Q46701862	Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer
Q50957755	Obesity-associated Breast Cancer: Analysis of risk factors.
Q36974351	Observational studies, clinical trials, and the women's health initiative
Q38787403	Oestrogen and anti-androgen therapy for transgender women.
Q33909569	Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
Q36292523	Oestrogen and stroke in women: assessment of risk
Q46778167	Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats
Q38526762	Oestrogen replacement in postmenopausal women
Q45898920	Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer.
Q33677382	Omega-3 fatty acids and cognitive function in women
Q34120300	On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause
Q37362306	Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study
Q34612492	Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity
Q46606644	Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
Q37237785	Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative
Q35312383	Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes
Q38169998	Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain
Q42596905	Oral contraceptives, hormone therapy and cardiovascular risk
Q46581962	Oral estrogen therapy in postmenopausal women is associated with loss of kidney function
Q24246213	Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
Q46899634	Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study
Q38232774	Ospemifene for the treatment of vulvovaginal atrophy and dyspareunia in postmenopausal women
Q38194966	Ospemifene in the treatment of vulvovaginal atrophy
Q30491704	Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data
Q36693328	Osteoimmunology
Q57417202	Osteoporosis
Q36809161	Osteoporosis and periodontal disease
Q36823703	Osteoporosis and skeletal fractures
Q46198558	Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors
Q36565785	Osteoporosis prevention and therapy: preserving and building strength through bone quality
Q37259927	Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement
Q36237854	Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach.
Q36583646	Osteoporosis: how should it be treated?
Q33631498	Osteoporosis: the current status of mesenchymal stem cell-based therapy
Q37864841	Outcome of lower extremity revascularization for peripheral artery occlusive disease: is there a difference between men and women?
Q36176937	Outcomes of deliveries by family physicians or obstetricians: a population-based cohort study using an instrumental variable
Q80356892	Ovarian cancer and HRT in the Million Women Study
Q36201810	Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice
Q35247222	Ovary-sparing hysterectomy: is it right for your patient?
Q58699564	PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
Q24536164	Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Q36761504	Pathways to ischemic neuronal cell death: are sex differences relevant?
Q26751149	Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
Q87828408	Patterns of menopausal hormone therapy use and hyperkyphosis in older women
Q36014291	Perceptions of clinical research participation among African American women
Q45194096	Peri-menopausal and post-menopausal experience among women with and without hormone replacement therapy
Q34184608	Perimenopausal risk factors and future health
Q38218301	Periodic Estrogen Receptor-Beta Activation: A Novel Approach to Prevent Ischemic Brain Damage
Q35638068	Peripheral Microvascular Vasodilatory Response to Estradiol and Genistein in Women with Insulin Resistance
Q36920505	Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population
Q38102040	Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.
Q46974098	Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women
Q24805037	Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women
Q36859988	Pharmacologic and nonpharmacologic management of osteoporosis
Q36920723	Pharmacologic interventions for the management of critical bleeding
Q34500111	Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts
Q61958756	Pharmacological postconditioning with the phytoestrogen genistein
Q28268346	Pharmacology of estrogens and progestogens: influence of different routes of administration
Q34380530	Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective
Q35855753	Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women
Q36739255	Pitfalls of the WHIs: Women's Health Initiative
Q38080771	Pituitary disease mortality: is it fiction?
Q34441060	Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials
Q34767292	Platelet reactivity and genetics down on the pharm.
Q38113819	Possible role of PGRMC1 in breast cancer development
Q28583479	Post-translational regulation of endothelial nitric oxide synthase (eNOS) by estrogens in the rat vagina
Q36871025	Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women
Q57300580	Postmenopausal Hormone Replacement Therapy and Risk of Acute Pancreatitis: A Population-Based Case-Control Study
Q33600109	Postmenopausal estrogen and progestin effects on the serum proteome
Q37995321	Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone
Q36427608	Postmenopausal hormone replacement therapy and venous thromboembolism.
Q42840295	Postmenopausal hormone therapy
Q35196707	Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions
Q35948658	Postmenopausal hormone therapy and breast cancer: a clinician's message for patients
Q35608346	Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis
Q37234323	Postmenopausal hormone therapy and cardiovascular disease in perspective
Q27008086	Postmenopausal hormone therapy and cognition
Q33516441	Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
Q36645889	Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women
Q38165230	Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women.
Q37180441	Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study
Q46066644	Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
Q37180460	Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study
Q40626144	Postmenopausal hormone therapy and the risk of breast cancer in Norway
Q34420014	Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke
Q37832031	Postmenopausal hormone therapy and venous thromboembolism
Q36041039	Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression
Q30451123	Postmenopausal hormone therapy: an Endocrine Society scientific statement.
Q38082563	Postmenopausal hormone therapy: risks and benefits
Q44241571	Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype
Q35801600	Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials
Q37193080	Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
Q61912706	Postmenopausal osteoporosis
Q80409527	Postmenopausal osteoporosis
Q35071491	Potential age-dependent effects of estrogen on neural injury
Q37156496	Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer
Q33621133	Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative
Q89355289	Predominant Role of Nuclear Versus Membrane Estrogen Receptor α in Arterial Protection: Implications for Estrogen Receptor α Modulation in Cardiovascular Prevention/Safety
Q34642847	Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
Q33681494	Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era.
Q28219238	Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?
Q37038535	Prevalent and Emerging Therapies for Osteoporosis
Q28221018	Preventing cardiovascular disease in women: an update
Q34140721	Prevention and treatment of venous thromboembolism during HRT: current perspectives
Q53499870	Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy.
Q44958136	Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools
Q35868030	Prevention of cancers of the breast, endometrium and ovary
Q38223587	Prevention of diseases after menopause.
Q37566044	Prevention, screening, and management of osteoporosis: an overview of the current strategies
Q37048218	Primary hyperparathyroidism and the skeleton
Q37968650	Primary prevention of cardiovascular disease with HRT.
Q38399459	Primary prevention of cardiovascular disease with hormone replacement therapy
Q22306369	Primary prevention of ischemic stroke
Q36695646	Primary systemic chemotherapy of invasive lobular carcinoma of the breast
Q45236376	Principles of drug literature evaluation for observational study designs
Q36515384	Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study
Q37048294	Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
Q37631072	Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue
Q34261512	Progesterone and Bone: Actions Promoting Bone Health in Women
Q35667831	Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cells
Q33687459	Progesterone and breast cancer.
Q37208037	Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats
Q37574428	Progesterone as a neuroprotective factor in traumatic and ischemic brain injury
Q28274391	Progesterone receptors: form and function in brain
Q37499223	Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women
Q34559509	Progesterone-only and non-hormonal contraception in the breast cancer survivor: Joint Review and Committee Opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada
Q46039879	Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.
Q38761522	Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors
Q34420425	Progestins and progesterone in hormone replacement therapy and the risk of breast cancer
Q36109111	Progestogen safety and tolerance in hormonal replacement therapy
Q38327714	Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells
Q24235130	Progestogens for hot flushes
Q26795567	Progestogens in menopausal hormone therapy
Q34317537	Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects
Q35056154	Progress in mining the human proteome for disease applications
Q37453973	Progress in osteoporosis and fracture prevention: focus on postmenopausal women
Q37147427	Proliferation of the superficial epithelium of ovaries in senile female rats following oral administration of conjugated equine estrogens
Q33851285	Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles
Q35526400	Prospective study of endogenous circulating estradiol and risk of stroke in older women
Q38759125	Protective effect of hormone therapy among women with hysterectomy/oophorectomy.
Q36377157	Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy
Q37261100	Provider attributes associated with hormone therapy prescribing frequency
Q54740073	Public health or private profit?
Q46486583	Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle
Q38750749	Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study
Q36224111	Racial and ethnic disparities in benign gynecologic conditions and associated surgeries
Q36614943	Racial disparities in advanced-stage colorectal cancer survival
Q46825529	Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS).
Q37633453	Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells
Q28478183	Raloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cells
Q36892891	Raloxifene for older women: a review of the literature
Q38825454	Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women
Q28181645	Randomized clinical stroke trials in 2004
Q31079547	Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha
Q51907394	Rashomon revisited: two views of monitoring the Women's Health Initiative trials.
Q40081930	Rational combination therapy in refractory migraine
Q36328011	Reaction to the recent publication by rosemary basson entitled 'testosterone therapy for reduced libido in women'.
Q45242556	Reasons why women in Turkey prefer short-term use of hormone replacement therapy (HRT).
Q81428041	Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trial
Q36946779	Recent epidemiological evidence relevant to the clinical management of the menopause
Q44278781	Recommendations on the management of fragility fracture risk in women younger than 70 years
Q34866458	Recurrence of endometriosis after hysterectomy
Q30409122	Reduction in menopause-related symptoms associated with use of a noninvasive neurotechnology for autocalibration of neural oscillations
Q37280726	Reduction of apoptosis and preservation of mitochondrial integrity under ischemia/reperfusion injury is mediated by estrogen receptor β.
Q35889648	Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Q45776038	Relationship between hormone replacement therapy and spinal osteoarthritis: a nationwide health survey analysis of the elderly Korean population
Q30409945	Relationship of elongated styloid process in digital panoramic radiography with carotid intima thickness and carotid atheroma in Doppler ultrasonography in osteoporotic females.
Q53250382	Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study.
Q36352735	Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy
Q34175422	Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation
Q33841626	Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition
Q50916380	Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.
Q38682158	Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative
Q30451655	Reproductive aging, menopause, and health outcomes
Q49957773	Reproductive endocrinology: Postmenopausal hormone therapy to prevent chronic conditions
Q34043346	Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease
Q38270981	Research priorities for the influence of gender on diagnostic imaging choices in the emergency department setting
Q53669167	Responses of urinary N-telopeptide and renal calcium handling to PTH infusion after treatment with estrogen, raloxifene, and tamoxifen.
Q27006022	Results of observational studies: analysis of findings from the Nurses' Health Study
Q34641857	Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).
Q34609608	Review of current treatment for hot flushes induced by androgen deprivation in prostate carcinoma
Q34211142	Revisiting estrogen: efficacy and safety for postmenopausal bone health
Q55400609	Risk Factors for Osteoporosis in Postmenopausal Women - from The Point of View of Primary Care Gynecologist.
Q36051449	Risk assessment: controversies and management of moderate- to high-risk individuals
Q35906333	Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation
Q35771145	Risk factors for cardiovascular disease and hormone therapy in women
Q33903091	Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population
Q34346863	Risk factors of breast cancer: a systematic review and meta-analysis
Q53810075	Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
Q53292939	Risk of breast cancer during hormone replacement therapy: mechanisms.
Q43244412	Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations
Q35179515	Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer
Q44927904	Risks and benefits of hormone therapy: has medical dogma now been overturned?
Q24647700	Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence
Q33772317	Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1/ mice with collagen-induced chronic arthritis
Q46727875	Role of inflammatory cytokines in the effect of estradiol on atheroma.
Q34029956	Role of phosphorylation in progesterone receptor signaling and specificity
Q35590308	Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women
Q30439872	Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Yin/Yang
Q38700757	Safety and benefit considerations for menopausal hormone therapy
Q38818327	Safety and comfort of long-term continuous combined transdermal estrogen and intrauterine levonorgestrel administration for postmenopausal hormone substitution - a review
Q85047203	Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study
Q34532021	Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
Q33949479	Safety of drugs used in the treatment of osteoporosis.
Q27011949	Salpingectomy as a means to reduce ovarian cancer risk
Q34362281	Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality
Q37813135	Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis
Q35946978	Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence
Q36132116	Secular trends in cardiovascular risk factors with a 36-year perspective: observations from 38- and 50-year-olds in the Population Study of Women in Gothenburg
Q35960350	Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia
Q36071309	Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model
Q85176448	Selective estrogen receptor modulators promising for cardiac syndrome X
Q34414882	Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative
Q33985881	Sequential Tests of Multiple Hypotheses Controlling Type I and II Familywise Error Rates
Q41151173	Serotonin in the Frontal Cortex: A Potential Therapeutic Target for Neurological Disorders
Q38955319	Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.
Q42338932	Sex Hormones and Colorectal Cancer: What Have We Learned So Far?
Q26744569	Sex and Gender Differences in Central Nervous System-Related Disorders
Q91706991	Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks
Q35198604	Sex differences in antiplatelet response in ischemic stroke
Q37172671	Sex differences in caspase activation after stroke
Q33864547	Sex differences in cognitive impairment and Alzheimer's disease
Q35509492	Sex differences in inflammation during atherosclerosis
Q82035418	Sex differences in stroke
Q38668357	Sex differences in vascular endothelial function and health in humans: impacts of exercise.
Q34581183	Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones
Q33739861	Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
Q37209551	Sex hormone levels and risk of breast cancer with estrogen plus progestin
Q37965428	Sex hormone replacement in Turner syndrome.
Q37651567	Sex hormone therapy and progression of cardiovascular disease in menopausal women
Q36854152	Sex hormones and the cardiovascular system: effects on arterial function in women.
Q60530603	Sex hormones and venous thromboembolism – from contraception to hormone replacement therapy
Q37130045	Sex hormones, their receptors and bone health
Q84159289	Sex modulates intestinal transformation by the tumor-suppressor GCC
Q35108211	Sex modulates intestinal transformation by the tumor-suppressor GCC.
Q36747053	Sex steroid effects at target tissues: mechanisms of action
Q36185871	Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke
Q50121638	Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials
Q35936499	Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial
Q35015991	Sharing clinical decisions by discussing evidence with patients
Q37440624	Short-term (1-2 mo) hormone therapy cessation before mammography
Q38473594	Short-term and long-term effects of osteoporosis therapies.
Q46383615	Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies
Q35396665	Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women
Q80482002	Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling
Q39337263	Should symptomatic menopausal women be offered hormone therapy?
Q35911820	Should tamoxifen be used in breast cancer prevention?
Q38609024	Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?
Q64122338	Side effects of drugs for osteoporosis and metastatic bone disease
Q50782648	Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
Q51546558	Simple Strategies for Vaginal Health Promotion in Cancer Survivors
Q36402165	Simultaneously testing for marginal genetic association and gene-environment interaction
Q37672759	Single- and multiple-dose pharmacokinetics of genistein capsules in healthy chinese subjects: A phase I, randomized, open-label study
Q36686101	Skin climacteric aging and hormone replacement therapy
Q37459710	Smoking may be considered an established risk factor for sporadic ALS.
Q58612308	Socioeconomic disparities in physical activity among Swedish women and trends over time - the population study of women in Gothenburg
Q37709873	Soy consumption during menopause
Q34245345	Soy diet worsens heart disease in mice.
Q36744585	Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary
Q36887077	Spinal and paraspinal lesions: the role of stereotactic body radiotherapy
Q35780153	Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70
Q41595188	State of the evidence 2017: an update on the connection between breast cancer and the environment
Q37408121	State of the evidence: the connection between breast cancer and the environment
Q36364054	Statistical issues arising in the Women's Health Initiative
Q55333269	Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance.
Q37809135	Steroid sulfatase and estrogen sulfotransferase in human carcinomas
Q37765941	Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders
Q34010677	Stress incontinence.
Q37058753	Stroke and the female brain
Q37608395	Stroke management in women
Q38975090	Study of oleanolic acid on the estrodiol production and the fat production of mouse preadipocyte 3T3-L1 in vitro
Q39194799	Supplementation of soy isoflavones improved sex hormones, blood pressure, and postmenopausal symptoms.
Q35927488	Surgical menopause and nonvertebral fracture risk among older US women
Q33854825	Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease
Q34570292	Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.
Q47650581	Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Q34619444	Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice
Q38126067	Systematic review about breast cancer incidence in relation to hormone replacement therapy use.
Q37954418	Systematic review of cardiovascular disease in women: assessing the risk.
Q33640377	TGFβ inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton
Q41856851	Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all.
Q54638546	Ten polymorphisms of estrogen-metabolizing genes and a family history of colon cancer--an association study of multiple gene-gene interactions.
Q36385057	Testing the critical window of estradiol replacement on gene expression of vasopressin, oxytocin, and their receptors, in the hypothalamus of aging female rats
Q33836874	Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study.
Q36475967	Testosterone replacement therapy for late-onset hypogonadism
Q36271731	Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents
Q33917513	The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women
Q90194537	The Controversial History of Hormone Replacement Therapy
Q39348201	The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy
Q41001595	The Evolution of the WHI 80+ Cohort
Q61771952	The HERACLES Cardiovascular Network
Q36892314	The HRT misuse and osteoporosis epidemic: a possible future scenario
Q21563448	The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
Q88450763	The Impact of Hormonal Contraceptives on Breast Cancer Pathology
Q89287973	The Influence of Menopausal Hormone Therapy and Potential Lifestyle Interactions in Female Cancer Development-a Population-Based Prospective Study
Q89622398	The Menstrual Cycle and Risk of Breast Cancer: A Review
Q36937937	The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Q92478886	The Role of 17β-Estradiol and Estrogen Receptors in Regulation of Ca2+ Channels and Mitochondrial Function in Cardiomyocytes
Q60923922	The Role of Menopausal Hormone Therapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis
Q48189748	The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause.
Q34276283	The WHI: the effect of hormone replacement therapy on fracture prevention
Q90052454	The Women's Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groups
Q46797789	The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline
Q36103525	The Women's Health Initiative study: perspectives and implications for clinical practice
Q38120650	The Women's Health Initiative: Hormone Therapy and Calcium/Vitamin D supplementation trials
Q33275630	The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial
Q34760979	The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?
Q30485457	The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk
Q51076396	The antiosteoporotic activity of central-icaritin (CIT) on bone metabolism of ovariectomized rats.
Q37254723	The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women
Q40190946	The association between an inflammatory diet and global cognitive function and incident dementia in older women: The Women's Health Initiative Memory Study.
Q36309256	The association between osteoporosis and oral bone loss
Q35590304	The association between soy nut consumption and decreased menopausal symptoms
Q93035279	The association of CASC16 variants with breast Cancer risk in a northwest Chinese female population
Q37126271	The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program
Q34426678	The association of hysterectomy and menopause: a prospective cohort study.
Q34932849	The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Q39017721	The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis
Q90153199	The clinical impact of estrogen loss on cardiovascular disease in menopausal females
Q22252596	The clinical management of BRCA1 and BRCA2 mutation carriers
Q39365235	The clinical potential of estrogen for the prevention of osteoarthritis: what is known and what needs to be done?
Q35928976	The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study
Q34733230	The continuing evolution of women's health
Q34555256	The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer
Q35001394	The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy.
Q36981426	The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature
Q46856543	The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
Q36704008	The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?
Q40439101	The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women
Q36094647	The current state of postmenopausal hormone therapy: update for neurologists and epileptologists
Q39347912	The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women.
Q36026408	The discovery and mechanism of action of letrozole
Q46914080	The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial
Q46797831	The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.
Q37361099	The effect of gonadectomy and estradiol on sensitivity to oxidative stress.
Q35552853	The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: protocol for a systematic review and meta-analysis
Q34268033	The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials
Q79754070	The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results
Q37942244	The effect of menopause on the skin and other connective tissues.
Q35904536	The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study
Q34783427	The effects of Cosmos caudatus (ulam raja) on dynamic and cellular bone histomorphometry in ovariectomized rats
Q28539057	The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton
Q36229442	The effects of aromatase inhibitors on lipids and thrombosis
Q43293543	The effects of hormone replacement therapy on myocardial performance in early postmenopausal women
Q36439357	The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats.
Q33838504	The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women
Q47102333	The effects of progesterones on blood lipids in hormone replacement therapy
Q36933363	The effects of tibolone in older postmenopausal women
Q30443688	The estrogen paradox
Q38993271	The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms
Q34493876	The flaws and human harms of animal experimentation
Q45557445	The history of hormone therapy use and recent controversy related to heart disease and breast cancer arising from prevention trial outcomes
Q34724578	The impact of clinical trials on the use of hormone replacement therapy. A population-based study
Q34722892	The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative
Q45106144	The implications of body fat mass and fat distribution for cognitive function in elderly women
Q85564716	The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data
Q37234088	The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
Q38763232	The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk
Q35564120	The influence of metabolic factors for nonalcoholic Fatty liver disease in women
Q35025648	The kaiser permanente interregional breast care leaders
Q35948678	The metabolic basis for the effects of HRT on coronary heart disease
Q35948648	The million women study: a critique
Q90661837	The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trials
Q37100398	The molecular actions of oestrogen in the regulation of vascular health
Q36598699	The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy
Q57203591	The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years
Q43418445	The negative impact of litigation on women's health care
Q35827822	The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer
Q45788428	The oestrogen paradox: an hypothesis
Q35638254	The pace of change in medical practice and health policy: collision or coexistence?
Q38003702	The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy
Q34592879	The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum
Q33930485	The potential association between postmenopausal hormone use and primary open-angle glaucoma
Q28263673	The potential for estrogens in preventing Alzheimer's disease and vascular dementia
Q25257485	The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells
Q36933312	The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
Q33654598	The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study
Q91949718	The relationship between menopausal hormone therapy and keratinocyte carcinoma: A review
Q36673808	The relationship between urban sprawl and coronary heart disease in women.
Q47278709	The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height
Q28283204	The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight
Q36447526	The risk of breast, endometrial and ovarian cancer in users of hormonal preparations
Q53250018	The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
Q36017502	The role of estrogen on the pathology of cerebral aneurysms
Q36864744	The role of estrogens in control of energy balance and glucose homeostasis
Q37145381	The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative
Q33949822	The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model
Q36236469	The role of mammographic density in evaluating changes in breast cancer risk
Q36946810	The role of menopausal hormone therapy in osteoporosis
Q38609082	The role of menopausal hormone therapy in the management of osteoporosis
Q28077795	The role of testosterone in colorectal carcinoma: pathomechanisms and open questions
Q46798956	The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemia.
Q38653057	The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis
Q38108388	The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 2: comparative risks
Q36781520	The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective
Q36806086	The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
Q37277298	The tissue selective estrogen complex: a promising new menopausal therapy
Q34498537	The transitioning from trials to extended follow-up studies
Q26992273	The treatment of climacteric symptoms
Q47291347	The weight problem
Q36432163	The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer
Q36467824	Therapeutic implications of the gender-specific aspects of cardiovascular disease
Q36331868	Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations
Q38150099	Therapy for patients with CKD and low bone mineral density
Q37768413	Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials
Q43227535	Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke
Q40315288	Time trends in breast cancer and menopause hormone therapy use in New Zealand
Q24626206	Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes
Q89308533	Timing of cyclic estradiol treatment differentially affects cognition in aged female rhesus monkeys
Q35858718	Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy
Q37304372	Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells.
Q37768158	Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms
Q33658348	Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells
Q52565586	Transdermal estradiol for the management of refractory uremic bleeding.
Q38765828	Transdermal estrogens in the changing landscape of hormone replacement therapy
Q37385612	Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies.
Q36376262	Translational approaches to addressing complex genetic pathways in colorectal cancer.
Q34271979	Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review
Q37060363	Treatment and prevention of osteoporosis.
Q36139976	Treatment of Men for "Low Testosterone": A Systematic Review
Q36219667	Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies
Q36213129	Treatment of menopausal symptoms: what shall we do now?
Q36134844	Treatment of menopause-related mood disturbances.
Q34896573	Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene
Q33876807	Treatment of the menopause: the swinging pendulum
Q37014593	Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity
Q79774306	Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis
Q48849554	Treatment with oestrogen-receptor agonists or oxytocin in conjunction with exercise protects against myocardial infarction in ovariectomized rats.
Q28248916	Trends and determinants of prescription medication use for treatment of osteoporosis
Q35068765	Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009
Q36600280	Tubal Ligation and Risk of Endometrial Cancer: Findings From the Women's Health Initiative
Q37274176	Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women
Q28550510	Twenty years and still counting: including women as participants and studying sex and gender in biomedical research
Q93043410	Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
Q35607220	Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors
Q36655236	Understanding the oestrogen action in experimental and clinical atherosclerosis.
Q36687457	Uniquely women's issues in colorectal cancer screening
Q36325450	Update in women's health 2006-2007.
Q28258998	Update on bazedoxifene: a novel selective estrogen receptor modulator
Q37989179	Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause
Q38106748	Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
Q48671400	Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health
Q30727710	Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.
Q51514495	Use of bisphosphonates and risk of breast cancer.
Q46064533	Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy
Q37359623	Use of gabapentin in patients experiencing hot flashes
Q37369812	Use of hormone replacement therapy and the risk of colorectal cancer
Q46259865	Use of oral contraceptives and postmenopausal hormone replacement: evidence on risk of stroke
Q37402842	Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings
Q46755164	Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
Q36528400	Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events
Q37245536	Using a global proteomic approach to identify proteins affected by estrogen therapy
Q30723397	Using the Whole Cohort in the Analysis of Case-Control Data: Application to the Women's Health Initiative
Q51351109	Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats.
Q85219201	VWF and ADAMTS13 behavior in estradiol-treated HUVEC
Q39999161	Vaginal estradiol use and the risk for cardiovascular mortality
Q37106120	Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative.
Q37438789	Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer
Q46944694	Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study
Q37088243	Vascular actions of estrogens: functional implications
Q36888620	Vascular and metabolic effects of sex steroids: new insights into clinical trials
Q46921475	Vasomotor symptom characteristics: are they risk factors for incident diabetes?
Q34565965	Vasomotor symptoms and coronary artery calcium in postmenopausal women
Q87958935	Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women
Q24631121	Venous thromboembolic disease
Q35815558	Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial
Q87383723	Vitamin D and diabetes
Q36608678	Vitamin D levels and menopause-related symptoms
Q34638176	Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial
Q37432269	We need a break: Bisphosphonates
Q35854642	Weight gain increases human aromatase expression in mammary gland
Q37964796	What are the real risks for breast cancer?
Q37672629	What can be done about hot flushes after treatment for breast cancer?
Q37929661	What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?
Q34485765	What have we learned about GPER function in physiology and disease from knockout mice?
Q81442396	What influence does hormone replacement therapy have on endometrial cancer risk?
Q37716669	What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
Q52371069	What the Women's Health Initiative has taught us about menopausal hormone therapy.
Q37995320	What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone
Q53220661	When practices, promises, profits, and policies outpace hard evidence: the post-menopausal hormone debate.
Q36350786	Where are we with postmenopausal hormone therapy in 2005?
Q45787376	Whether the use of unopposed oestrogen following a myocardial infarction is beneficial or harmful remains unclear, and in individual women the effects may vary according to the underlying risk profile
Q36945575	Which gender is better positioned in the process of liver surgery? Male or female?
Q36488503	Why do some breast cancer cells remain dormant?
Q38253965	Why do statins reduce cardiovascular disease more than other lipid modulating therapies?
Q37760526	Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis
Q42229710	Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
Q36467025	Wnt-signaling-mediated antiosteoporotic activity of porcine placenta hydrolysates in ovariectomized rats
Q37286086	Women and heart disease: neglected directions for future research
Q36839180	Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up
Q37315529	Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy
Q81060896	Women's Health Initiative data--what were the real conclusions and how will these studies impact the pelvic floor?
Q52000029	Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
Q37101516	Women's health in menopause with a focus on hypertension
Q54740039	Women's health initiative view of estrogen avoidance and all-cause mortality.
Q46669129	Women's perception of the efficacy of a soy extract with probiotic: the M3 study
Q30354786	Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
Q50974646	Young Coconut Juice Supplementation Results in Greater Bone Mass and Bone Formation Indices in Ovariectomized Rats: A Preliminary Study.
Q51036208	Z-Bisdehydrodoisynolic acid (Z-BDDA): An estrogenic seco-steroid that enhances behavioral recovery following moderate fluid percussion brain injury in male rats
Q33787731	Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy
Q80903366	[Cardiovascular risk in the "Women's Health Initiative". Much ado about nothing?]
Q81669735	[Current role of hormone replacement therapy in the prevention of postmenopausal osteoporosis: gynecologic point of view]
Q79210166	[Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk]
Q39329106	[Menopausal hormone therapy].
Q81696967	[Osteoporosis and hormone replacement therapy]
Q81318310	[Postmenopausal hormone therapy and vascular risk]
Q81420397	[Role of hormone-replacement therapy for prevention of coronary artery disease in women]
Q83950697	[Should we change our attitude on postmenopausal hormone replacement therapy?]
Q84341201	[Surrogate end points--somewhere between essential and not worth discussing]
Q81591791	[Update on menopause treatments, after recent controversies]
Q81079871	[Will publication of the French study E3N change prescription practices for hormone replacement therapy in menopausal women?]
Q35096710	ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells

P356	DOI	10.1001/JAMA.291.14.1701
P3181	OpenCitations bibliographic resource ID	1200168
P698	PubMed publication ID	15082697

P50	author	JoAnn E. Manson	Q6204013
		Andrea LaCroix	Q28360453
		Jean Wactawski-Wende	Q30001860
		Sylvia Wassertheil-Smoller	Q30002263
		Gerardo Heiss	Q30004039
		George A. Howard	Q56245986
		Robert D. Langer	Q62663116
		Karen L. Margolis	Q67453328
		Rebecca D. Jackson	Q72504541
		Shirley A A Beresford	Q87414169
		Marcia L. Stefanick	Q109542605
P2093	author name string	Anderson GL
		Assaf AR
		Bassford T
		Black H
		Bonds D
		Brunner R
		Brzyski R
		Caan B
		Chlebowski R
		Curb D
		Gass M
		Hays J
		Hendrix S
		Hsia J
		Hubbell A
		Johnson KC
		Judd H
		Kotchen JM
		Kuller L
		Lane D
		Lasser N
		Lewis CE
		Limacher M
		O'Sullivan MJ
		Ockene J
		Phillips L
		Prentice RL
		Ritenbaugh C
		Robbins J
		Rossouw JE
		Sarto G
		Van Horn L
		Wallace R
P433	issue	14
P407	language of work or name	English	Q1860
P921	main subject	estrogen	Q277954
		women's health	Q8031191
		hysterectomy	Q550675
		randomized controlled trial	Q1436668
P304	page(s)	1701-12
P577	publication date	2004-04-14
P1433	published in	The Journal of the American Medical Association	Q1470970
P1476	title	Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
P478	volume	291

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

scientific article (publication date: 14 April 2004)

Reverse relations